SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Munch-a-Biotech Today
An SI Board Since December 1998
Posts SubjectMarks Bans
3158 136 0
Emcee:  Biomaven Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2883GILD munches the Branford CT private company Cellular Genomics (CGI). finance.yBiotech Jim-6/25/2010
2882Biovail munches Valeant U.S.-based Valeant Pharmaceuticals International (VRXIan@SI-6/21/2010
2881JAV/HSP: Hospira then licenses a long acting anesthetic from Durect, also for tuck-6/8/2010
2880Grifols to Acquire TLCR for $3B in Cash+Stock—WSJ: siliconinvestor.comDewDiligence_on_SI-6/6/2010
2879And the JAV/HSP merger goes Jekyl/Hyde as Javelin sues for completion and HSP ctuck-6/3/2010
2878Re: Javelin/Hospira deal: "Certainly sounds like a material adverse event.tuck-6/1/2010
2877Top five oncology takeover targets for 2010 - analysis By Sasha Damouni and Nadsim1-6/1/2010
2876Surprised to find these guys still exist: VaxGen Inc. will acquire diaDexus Incnigel bates-5/28/2010
2875Certainly sounds like a material adverse event. If the 2 parties still really wIan@SI-5/24/2010
2874The "supply chain problem" is a biggie: Press Release Source: Javelintuck-5/24/2010
2873More info on why I like today’s ABT deal a lot: siliconinvestor.comDewDiligence_on_SI-5/21/2010
2872ABT Acquires Piramal’s Drug Business for $3.7B in Cash: siliconinvestor.comDewDiligence_on_SI-5/21/2010
2871I'm not following this situation closely, but I doubt that HSP is a party toDewDiligence_on_SI-5/20/2010
2870It's been noted on IHub that HSP has extended it tender offer to June 2nd, tuck-5/20/2010
2869OSI is taken under at $57.50 by Astellas. Apparently no one else was interested pgo-neil-5/17/2010
2868May 13 (Reuters) - Agriculture biotechnology firm FuturaGene said its Brazilian nigel bates-5/13/2010
2867Charles River Labs Munches WuXi Pharmatech for 28% premium. bloomberg.com Cheetuck-4/26/2010
2866The reason is that JAV is being acquired by HSP.DewDiligence_on_SI-4/19/2010
2865>>Javelin Pharmaceuticals Announces Termination of Merger Agreement with Mtuck-4/19/2010
2864Sandoz Acquires Oriel Therapeutics for Undisclosed Sum: siliconinvestor.comDewDiligence_on_SI-4/19/2010
2863Leading Biotechnology Mergers and Acquisitions for the 10-Year Period Ended DeceBiomaven-3/31/2010
2862OSI trades a deeper look at the books for time to find a white knight . . .tuck-3/30/2010
2861OSI rejected the bid this past Monday. Stock is trading just below $59, so obvituck-3/19/2010
2860>>They missed FACT :-) Me too. But rkrw didn't. :) PeterBiomaven-3/9/2010
2859Background read on ABT’s unequaled expertise in biotech buyouts: siliconinvestoDewDiligence_on_SI-3/9/2010
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News